Ferty9 Leads India in Fertility Revolution with Expert Appointment

Over 30 million Indian couples face infertility challenges, prompting Ferty9 Fertility Centre to appoint Prof. Roy Homburg as Clinical Research Advisor. This strategic move aims to enhance fertility research specific to India's unique genetic diversity. Ferty9 strives to advance reproductive healthcare through localized, evidence-based studies under Prof. Homburg's guidance.

Hyderabad, October 14th, 2025: Ferty9 Fertility Centre is addressing India's looming fertility crisis by appointing globally acclaimed expert Prof. Roy Homburg as Clinical Research Advisor. This selection aligns with the Centre's mission to integrate international expertise with India's distinctive reproductive health demands.

The announcement follows Fertygyaan 2025, an influential conference uniting global fertility specialists to explore innovative clinical trends. Prof. Homburg plans to develop large-scale IVF studies tailored to India's genetic landscape, addressing significant research gaps due to inadequate infrastructure.

Dr. Jyothi, Medical Director at Ferty9, emphasized the necessity of India-specific studies, citing urgent demographic implications. By leveraging Ferty9's state-of-the-art facilities and Prof. Homburg's mentorship, the Centre aims to revolutionize fertility care across India, ultimately benefiting millions affected by infertility.

(With inputs from agencies.)